GlobeNewswire by notified

NAT Global Campus Signs 3 More High Flyers to Meet the Demand for Quality Education Online

Share

Spiralling Growth in Consumer Demand for Natural Alternative Therapies Driving Healthcare Professionals to Spend More Time Learning Online

ORLANDO, Fla., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Niel Asher Education is pleased to announce that three dynamic new faculty members will join NAT Global Campus in spring 2023. The addition of these leading experts and innovators in the fields of Manual Medicine and Traditional Chinese Medicine further demonstrates its commitment to providing its student community with the highest standards of education online.

Dr. Constance Bradley, L.Ac., Ph.D., will present NAT courses on acupuncture and TCM. Dr. Bradley attended the US Air Force Academy, receiving a Bachelor of Science in Humanities in 2001. In 2002, she graduated from the University of Colorado, receiving a Master of Arts in Philosophy with an emphasis in Medical Ethics. In 2009 she received her Doctorate from the University of Utah.

"Niel Asher leads the way in providing top-notch continuing education, and I am honored to join their team. I look forward to sharing my Traditional Chinese Medicine expertise, and I am very excited to work with Niel Asher to create high-quality, informative courses," she said.

Dr. Linda Bluestein, MD, is a Board-certified anesthesiologist, integrative pain medicine physician and former ballet dancer, who specializes in treating dancers and other athletes at increased risk of hyper-mobility and connective tissue disorders such as EDS.

Dr. Bluestein completed her anesthesiology residency at the Mayo Graduate School of Medicine after receiving her Medical Degree from the University of California, Los Angeles School of Medicine and is a member of the International Association for Dance Medicine and Science, the Performing Arts Medicine Association, and the Resources Committee for the Dance Healthy Alliance of Canada.

"I am thrilled to work with Niel Asher Education to create courses on symptomatic joint hypermobility.  It is exciting to work with them on educational offerings about these frequently misunderstood and complex conditions," she said.

Dr. Elizabeth Wagner, Ph.D., earned her Doctorate in Physical Therapy from the University of Washington. She has also earned a certificate of competency in vestibular rehabilitation and is certified in Mechanical Diagnosis and Therapy.

"I am thrilled to collaborate with NAT to create high-quality continuing education courses. I look forward to contributing my 15 years of experience as a physical therapist and teacher to NAT's ongoing efforts of supporting this vibrant community," she said.

The NAT Global Campus has grown to become one of the largest online schools for Natural Alternative Therapies in manual medicine and serves over 100,000 students in over 40 countries.

NAT Global Campus' Director Dani P. Marks stated, "Our most significant health challenges continually demand fresh takes and multidisciplinary approaches. This group of outstanding new faculty is joining a team of specialist teachers committed to deliver on this promise, and to help provide our students with the skills and knowledge to improve outcomes and provide outstanding care in their communities."

Contact Information:
Dani Marks
Interim Director, NAT Global Campus
dani@nielasher.com
8147771964

Related Images



To view this piece of content from cdn.newswire.com, please give your consent at the top of this page.


Image 1: Niel Asher Education



This content was issued through the press release distribution service at Newswire.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

Novo Nordisk A/S - share repurchase programme6.5.2024 20:44:48 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 2.2 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”). The purpose of the programme is to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes. B shares of DKK 0.10 will be repurchased during the trading period starting 7 May 2024 and ending on 5 August 2024. A maximum of 350,000,000 B shares of DKK 0.10 in total can be bought during the trading period. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our

Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme6.5.2024 20:40:01 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S’ 2024 share repurchase programme of up to a total of DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. The transaction price is DKK 860.02 per share and has been calculated as the three-day volume weighted average market price from 2 May 2024 to 6 May 2024 in the open window following the announcement of Novo Nordisk A/S’ quarterly financial results. Prior to the sale of B shares, Novo Holdings A/S’ ownership of Novo Nordisk A/S was 28.3% of the share capital and 77.4% of the votes. Following the transaction, Novo Holdings A/S owns 1,074,872,000 A shares of DKK 0.10 and 183,871,750 B shares of DKK 0.10, corresponding to 28.2% of the capital and 77.3% of the votes in Novo Nordisk A/S. The transaction is in line with th

Aktia Bank Abp: Anmälan om ändring av ägarandel i enlighet med kapitel 9 paragraf 10 i värdepappersmarknadslagen (Erkki Etolas ägarkontrollerade bolag)6.5.2024 19:30:00 CEST | Pressemelding

Aktia Bank Abp Börsmeddelande 6.5.2024 kl. 20.30 Aktia Bank Abp: Anmälan om ändring av ägarandel i enlighet med kapitel 9 paragraf 10 i värdepappersmarknadslagen (Erkki Etolas ägarkontrollerade bolag) Aktia Bank Abp har i enlighet med kapitel 9 paragraf 5 i värdepappersmarknadslagen emottagit anmälan av Erkki Etola, enligt vilken det av Erkki Etola kontrollerade bolaget Etola Group Oy:s innehav överskrider gränsen på 5 % av antalet aktier och röster i Aktia Bank Abp. De av Erkki Etola kontrollerade bolagens sammanlagda innehav av aktier och röster i Aktia Bank Abp överskrider inte flaggningsgränserna. Den information om aktieinnehav som presenteras i flaggningsmeddelandet återspeglar situationen efter de aktietransaktioner som genomfördes 6.5.2024. Det totala aktieinnehavet i Erkki Etolas kontrollerande bolag är oförändrat (9,75 %). Etola Group Oy:s aktieinnehav har redan överskridit gränsen på 5 % i och med aktieaffären 16.11.2023 och uppgick till 5,03 %. Detta överskridande har inte

HiddenA line styled icon from Orion Icon Library.Eye